These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18321635)

  • 1. Prediction of the binding modes between BB-83698 and peptide deformylase from Bacillus stearothermophilus by docking and molecular dynamics simulation.
    Wang Q; Wang J; Cai Z; Xu W
    Biophys Chem; 2008 May; 134(3):178-84. PubMed ID: 18321635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
    Boularot A; Giglione C; Petit S; Duroc Y; Alves de Sousa R; Larue V; Cresteil T; Dardel F; Artaud I; Meinnel T
    J Med Chem; 2007 Jan; 50(1):10-20. PubMed ID: 17201406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of peptide deformylase from Staphylococcus aureus in complex with actinonin, a naturally occurring antibacterial agent.
    Yoon HJ; Kim HL; Lee SK; Kim HW; Kim HW; Lee JY; Mikami B; Suh SW
    Proteins; 2004 Nov; 57(3):639-42. PubMed ID: 15382235
    [No Abstract]   [Full Text] [Related]  

  • 4. Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets.
    Wang Q; Zhang D; Wang J; Cai Z; Xu W
    Biophys Chem; 2006 Jun; 122(1):43-9. PubMed ID: 16545516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors.
    Yan C; Xiu Z; Li X; Li S; Hao C; Teng H
    Proteins; 2008 Oct; 73(1):134-49. PubMed ID: 18398905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
    Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M
    In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity.
    Alam MA; Naik PK
    J Mol Graph Model; 2009; 27(8):930-43. PubMed ID: 19286405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into activation and RNA binding of trp RNA-binding attenuation protein (TRAP) through all-atom simulations.
    Murtola T; Vattulainen I; Falck E
    Proteins; 2008 Jun; 71(4):1995-2011. PubMed ID: 18186477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method.
    Li X; Zhang W; Qiao X; Xu X
    Bioorg Med Chem; 2007 Jan; 15(1):220-6. PubMed ID: 17064917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining docking, molecular dynamics and the linear interaction energy method to predict binding modes and affinities for non-nucleoside inhibitors to HIV-1 reverse transcriptase.
    Carlsson J; Boukharta L; Aqvist J
    J Med Chem; 2008 May; 51(9):2648-56. PubMed ID: 18410085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
    Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-inhibitor flexible docking by a multicanonical sampling: native complex structure with the lowest free energy and a free-energy barrier distinguishing the native complex from the others.
    Kamiya N; Yonezawa Y; Nakamura H; Higo J
    Proteins; 2008 Jan; 70(1):41-53. PubMed ID: 17636570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Docking modes of BB-3497 into the PDF active site--a comparison of the pure MM and QM/MM based docking strategies.
    Kumari T; Issar U; Kakkar R
    Curr Comput Aided Drug Des; 2014; 10(4):315-26. PubMed ID: 25994638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.
    Gutiérrez-de-Terán H; Nervall M; Dunn BM; Clemente JC; Aqvist J
    FEBS Lett; 2006 Oct; 580(25):5910-6. PubMed ID: 17045991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-cleaving catalyst selective for peptide deformylase.
    Chae PS; Kim MS; Jeung CS; Lee SD; Park H; Lee S; Suh J
    J Am Chem Soc; 2005 Mar; 127(8):2396-7. PubMed ID: 15724986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Mg2+ on the binding modes of HIV-1 integrase with thiazolothiazepine inhibitor studied by molecular simulation.
    Wang L
    Comput Biol Med; 2009 Apr; 39(4):355-60. PubMed ID: 19268284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are automated molecular dynamics simulations and binding free energy calculations realistic tools in lead optimization? An evaluation of the linear interaction energy (LIE) method.
    Stjernschantz E; Marelius J; Medina C; Jacobsson M; Vermeulen NP; Oostenbrink C
    J Chem Inf Model; 2006; 46(5):1972-83. PubMed ID: 16995728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting binding modes from free energy calculations.
    Nervall M; Hanspers P; Carlsson J; Boukharta L; Aqvist J
    J Med Chem; 2008 May; 51(9):2657-67. PubMed ID: 18410080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.